216 related articles for article (PubMed ID: 23176379)
1. Anti-atherosclerotic therapy based on botanicals.
Orekhov AN; Sobenin IA; Korneev NV; Kirichenko TV; Myasoedova VA; Melnichenko AA; Balcells M; Edelman ER; Bobryshev YV
Recent Pat Cardiovasc Drug Discov; 2013 Apr; 8(1):56-66. PubMed ID: 23176379
[TBL] [Abstract][Full Text] [Related]
2. Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.
Orekhov AN
Curr Pharm Des; 2013; 19(33):5909-28. PubMed ID: 23438951
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogen-Rich Natural Preparation for Treatment of Climacteric Syndrome and Atherosclerosis Prevention in Perimenopausal Women.
Kirichenko TV; Myasoedova VA; Orekhova VA; Ravani AL; Nikitina NA; Grechko AV; Sobenin IA; Orekhov AN
Phytother Res; 2017 Aug; 31(8):1209-1214. PubMed ID: 28593720
[TBL] [Abstract][Full Text] [Related]
4. Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.
Myasoedova VA; Kirichenko TV; Melnichenko AA; Orekhova VA; Ravani A; Poggio P; Sobenin IA; Bobryshev YV; Orekhov AN
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529226
[TBL] [Abstract][Full Text] [Related]
5. Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills.
Karagodin VP; Sobenin IA; Orekhov AN
Curr Pharm Des; 2016; 22(2):196-213. PubMed ID: 26561055
[TBL] [Abstract][Full Text] [Related]
6. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
Hodis HN; Mack WJ; LaBree L; Selzer RH; Liu C; Liu C; Alaupovic P; Kwong-Fu H; Azen SP
Ann Intern Med; 1996 Mar; 124(6):548-56. PubMed ID: 8597317
[TBL] [Abstract][Full Text] [Related]
7. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).
Ikeda K; Takahashi T; Yamada H; Matsui K; Sawada T; Nakamura T; Matsubara H;
Eur J Prev Cardiol; 2013 Dec; 20(6):1069-79. PubMed ID: 22689416
[TBL] [Abstract][Full Text] [Related]
9. Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study.
Baldassarre D; Veglia F; Gobbi C; Gallus G; Ventura A; Crepaldi G; Fisicaro M; Rimondi S; Ricci G; Mancini M; Bong MG; Collatina S; Sirtori CR
Atherosclerosis; 2000 Aug; 151(2):575-83. PubMed ID: 10924737
[TBL] [Abstract][Full Text] [Related]
10. Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: a post hoc analysis of the NORMALISE and PREVENT studies.
Kim JS; Park S; Yan P; Jeffers BW; Cerezo C
Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):82-89. PubMed ID: 27533954
[TBL] [Abstract][Full Text] [Related]
11. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Furberg CD; Adams HP; Applegate WB; Byington RP; Espeland MA; Hartwell T; Hunninghake DB; Lefkowitz DS; Probstfield J; Riley WA
Circulation; 1994 Oct; 90(4):1679-87. PubMed ID: 7734010
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
[TBL] [Abstract][Full Text] [Related]
13. Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study.
Seo WK; Kim YJ; Lee J; Kwon SU;
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1892-1898. PubMed ID: 28739344
[TBL] [Abstract][Full Text] [Related]
14. Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy.
Myasoedova VA; Ivashinnikova GA; Sobenin IA; Ivanova EA; Orekhov AN
Curr Pharm Des; 2017; 23(8):1195-1206. PubMed ID: 28042768
[TBL] [Abstract][Full Text] [Related]
15. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
[TBL] [Abstract][Full Text] [Related]
16. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study.
Wiklund O; Hulthe J; Wikstrand J; Schmidt C; Olofsson SO; Bondjers G
Stroke; 2002 Feb; 33(2):572-7. PubMed ID: 11823672
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD
Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.
Salonen JT; Nyyssönen K; Salonen R; Lakka HM; Kaikkonen J; Porkkala-Sarataho E; Voutilainen S; Lakka TA; Rissanen T; Leskinen L; Tuomainen TP; Valkonen VP; Ristonmaa U; Poulsen HE
J Intern Med; 2000 Nov; 248(5):377-86. PubMed ID: 11123502
[TBL] [Abstract][Full Text] [Related]
19. Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment.
Hallengren E; Almgren P; Rosvall M; Östling G; Persson M; Bergmann A; Struck J; Engström G; Hedblad B; Melander O
BMC Cardiovasc Disord; 2017 May; 17(1):125. PubMed ID: 28511669
[TBL] [Abstract][Full Text] [Related]
20. Anti-cytokine therapy for prevention of atherosclerosis.
Kirichenko TV; Sobenin IA; Nikolic D; Rizzo M; Orekhov AN
Phytomedicine; 2016 Oct; 23(11):1198-210. PubMed ID: 26781385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
